Lv1
60 积分 2024-03-09 加入
Efficacy and safety of branebrutinib (BMS-986195), an irreversible Bruton's tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2a, randomised, double-blind, placebo-controlled study
4个月前
已关闭
Promise of rheumatoid arthritis therapy: From clinical deep remission to drug-free remission
7个月前
已完结
皖公网安备34019202002308
